1. Clinical perspectives of BET inhibition in ovarian cancer

   • Angeliki Andrikopoulou
   • Michalis Liontos
   • Flora Zagouri

   Review 19 January 2021 Pages: 237 - 249

2. Organoid technology for personalized pancreatic cancer therapy

   • Axel Bengtsson
   • Roland Andersson
   • Daniel Ansari

   Review Open access 25 January 2021 Pages: 251 - 260

   

3. Immunotherapy for pancreatic cancer: chasing the light at the end of the tunnel

   • Thomas P. Brouwer
   • Alexander L. Vahrmeijer
   • Noel F. C. C. de Miranda

   Review Open access 12 March 2021 Pages: 261 - 278

   

4. Circular RNA circ-102,166 acts as a sponge of miR-182 and miR-184 to suppress hepatocellular carcinoma proliferation and invasion

   • Rong Li
   • Yinan Deng
   • Wei Liu

   Original paper 09 October 2020 Pages: 279 - 295

   

5. Circular RNA circCSNK1G3 induces HOXA10 signaling and promotes the growth and metastasis of lung adenocarcinoma cells through hsa-miR-143-3p sponging

   • Tong Lu
   • Tong Qiu
   • Wenjie Jiao

   Original paper 29 October 2020 Pages: 297 - 310

   

6. Chronic exercise training attenuates prostate cancer-induced molecular remodelling in the testis

   • Bárbara Matos
   • Daniela Patrício
   • Margarida Fardilha

   Original paper 19 October 2020 Pages: 311 - 327

   

7. Ubiquitin-specific protease 2a promotes hepatocellular carcinoma progression via deubiquitination and stabilization of RAB1A

   • Bin Xiong
   • Junwei Huang
   • Chan Qiu

   Original paper 19 October 2020 Pages: 329 - 343

   

8. CREPT serves as a biomarker of poor survival in pancreatic ductal adenocarcinoma

   • Gang Yang
   • Yicheng Wang
   • Yupei Zhao

   Original Article 30 October 2020 Pages: 345 - 355

   

9. AKR1C3 is a biomarker and druggable target for oropharyngeal tumors

   • Caterina Peraldo-Neia
   • Paola Ostano
   • Giovanna Chiorino

   Original Article 19 November 2020 Pages: 357 - 372

   

10. Porphyromonas gingivalis promotes tumor progression in esophageal squamous cell carcinoma

    • Miao-Fen Chen
    • Ming-Shian Lu
    • Wen-Cheng Chen

    Original paper 17 November 2020 Pages: 373 - 384

    

11. Glutaminolysis is a metabolic route essential for survival and growth of prostate cancer cells and a target of 5α-dihydrotestosterone regulation

    • Henrique J. Cardoso
    • Marília I. Figueira
    • Sílvia Socorro

    Original paper 19 January 2021 Pages: 385 - 403

    

12. Tweaking EMT and MDR dynamics to constrain triple-negative breast cancer invasiveness by EGFR and Wnt/β-catenin signaling regulation

    • Rajib Shome
    • Siddhartha Sankar Ghosh

    Original paper 04 January 2021 Pages: 405 - 422

    

13. PD-1 and PD-L2 expression predict relapse risk and poor survival in patients with stage III colorectal cancer

    • Mehmet Zengin
    • Sema Zergeroğlu
    • Suat Benek

    Original Paper 19 January 2021 Pages: 423 - 432

    

14. Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS

    • Sonam Takkar
    • Vikas Sharma
    • Ritu Kulshreshtha

    Original Article 19 January 2021 Pages: 433 - 451

    

15. CHRNA5 belongs to the secondary estrogen signaling network exhibiting prognostic significance in breast cancer

    • Huma Shehwana
    • Ayse G. Keskus
    • Ozlen Konu

    Original Article 19 January 2021 Pages: 453 - 472